Oral Pre-Exopsure Prophylaxis
WHO recommends that people at substantial risk of HIV infection should be offered tenofovir disoproxil fumarate (TDF)-based oral PrEP as an additional prevention choice, as part of comprehensive prevention. 2 CPD's allocated.